Search Count: 16
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2021-01-13 Classification: CYTOKINE Ligands: UTJ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2021-01-13 Classification: CYTOKINE Ligands: UTM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.83 Å Release Date: 2021-01-13 Classification: CYTOKINE Ligands: UTS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2021-01-13 Classification: CYTOKINE Ligands: UTV |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.93 Å Release Date: 2021-01-13 Classification: CYTOKINE Ligands: UTY |
 |
Structure-Guided Optimization Of A Novel Class Of Ask1 Inhibitors With Increased Sp3 Character And An Exquisite Selectivity Profile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2020-08-12 Classification: METAL BINDING PROTEIN Ligands: V3S |
 |
Crystal Structure Of Protein Kinase A In Complex With The Pki Peptide And Aminobenzothiazole Based Inhibitor
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2018-01-31 Classification: TRANSFERASE Ligands: 9CY |
 |
Crystal Structure Of Protein Kinase A In Complex With The Pki Peptide And Aminobenzothiazole Based Inhibitors
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2018-01-31 Classification: TRANSFERASE Ligands: 9D4 |
 |
Crystal Structure Of Protein Kinase A In Complex With The Pki Peptide And Aminobenzothiazole Based Inhibitors
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.37 Å Release Date: 2018-01-31 Classification: TRANSFERASE Ligands: 9D1 |
 |
Structure-Based Design Of Ask1 Inhibitors As Potential First-In-Class Agents For Heart Failure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2017-06-07 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: SO4, 8GV |
 |
Structure-Based Design Of Ask1 Inhibitors As Potential First-In-Class Agents For Heart Failure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2017-06-07 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8GY |
 |
Structure-Based Design Of Ask1 Inhibitors As Potential First-In-Class Agents For Heart Failure
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.95 Å Release Date: 2017-06-07 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8GS |
 |
Structure-Based Drug Design Of Novel Ask1 Inhibitors Using A Fully Integrated Lead Optimization Strategy
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2017-03-29 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8V4 |
 |
Structure-Based Drug Design Of Novel Ask1 Inhibitors Using A Fully Integrated Lead Optimization Strategy
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2017-03-29 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8V7 |
 |
Crystal Structure Of Human Mcl-1 Bound To Inhibitor 4-(4-Methylnaphthalen-1-Yl)-2-{[(4-Phenoxyphenyl)Sulfonyl]Amino}Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.86 Å Release Date: 2014-03-12 Classification: APOPTOSIS/INHIBITOR Ligands: 2UU |
 |
Crystal Structure Of Human Mcl-1 Bound To Inhibitor 4-Hydroxy-4'-Propylbiphenyl-3-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2014-03-12 Classification: APOPTOSIS/INHIBITOR Ligands: 2UV |